+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Continuous Bioprocessing Market Research Report by Product (Bioreactors, Cell Culture Media & Reagent, and Centrifuges), End-User, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5012940
  • Report
  • April 2022
  • Region: Global
  • 180 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022
The Global Continuous Bioprocessing Market size was estimated at USD 7,813.37 million in 2020, USD 8,795.43 million in 2021, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 12.69% to reach USD 16,006.03 million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Continuous Bioprocessing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Bioreactors, Cell Culture Media & Reagent, Centrifuges, Chromatography System & Consumable, Filtration Systems and Consumables, Incubators & Shakers, and Mixing Systems.
  • Based on End-User, the market was studied across Academic & Research Institutes, Contract Development & Manufacturing Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Application, the market was studied across Commercial and Research & Development. The Commercial is further studied across Cell & Gene Therapy Production, Monoclonal Antibodies Production, Plasma Fractionation, Recombinant Protein Production, and Vaccine Manufacturing.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Continuous Bioprocessing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Continuous Bioprocessing Market, including 3M Company, Applikon Biotechnology B.V., Bio-Rad Laboratories, Inc., Bionet, Colder Products Company, Danaher Corporation, Eppendorf AG, Fujifilm Holdings Corporation, GE Healthcare, Lonza Group, Merck KGaA, Repligen Corporation, Sartorius AG, Thermo Fisher Scientific Inc., Watson-Marlow Fluid Technology Group, and WuXi Biologics.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Continuous Bioprocessing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Continuous Bioprocessing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Continuous Bioprocessing Market?
4. What is the competitive strategic window for opportunities in the Global Continuous Bioprocessing Market?
5. What are the technology trends and regulatory frameworks in the Global Continuous Bioprocessing Market?
6. What is the market share of the leading vendors in the Global Continuous Bioprocessing Market?
7. What modes and strategic moves are considered suitable for entering the Global Continuous Bioprocessing Market?
Frequently Asked Questions about the Global Continuous Bioprocessing Market

What is the estimated value of the Global Continuous Bioprocessing Market?

The Global Continuous Bioprocessing Market was estimated to be valued at $7813.4 Million in 2020.

What is the growth rate of the Global Continuous Bioprocessing Market?

The growth rate of the Global Continuous Bioprocessing Market is 12.6%, with an estimated value of $16006.0 Million by 2026.

What is the forecasted size of the Global Continuous Bioprocessing Market?

The Global Continuous Bioprocessing Market is estimated to be worth $16006.0 Million by 2026.

Who are the key companies in the Global Continuous Bioprocessing Market?

Key companies in the Global Continuous Bioprocessing Market include 3M Company, Applikon Biotechnology B.V., Bio, Rad Laboratories, Inc., Bionet, Colder Products Company, Danaher Corporation, Eppendorf AG and GE Healthcare.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Demand for Biopharmaceuticals & Government Support for the Industry
5.1.1.2. Increased Benefits over Batch Processing & Uptake of Single Use Technology
5.1.1.3. Advent of Industry 4.0 & Trend Towards Automation & Digitization
5.1.2. Restraints
5.1.2.1. Strict Regulations for Continuous Bioprocessing Coupled with High Equipment Cost
5.1.3. Opportunities
5.1.3.1. Adoption of Perfusion Associated with Single-Use Equipment
5.1.3.2. Development of a Continuous Bioprocessing Approach to Stromal Cell Manufacturing
5.1.4. Challenges
5.1.4.1. Issues with Operational Difficulties and Process Changes
5.2. Cumulative Impact of COVID-19
6. Continuous Bioprocessing Market, by Product
6.1. Introduction
6.2. Bioreactors
6.3. Cell Culture Media & Reagent
6.4. Centrifuges
6.5. Chromatography System & Consumable
6.6. Filtration Systems and Consumables
6.7. Incubators & Shakers
6.8. Mixing Systems
7. Continuous Bioprocessing Market, by End-User
7.1. Introduction
7.2. Academic & Research Institutes
7.3. Contract Development & Manufacturing Organizations
7.4. Pharmaceutical & Biotechnology Companies
8. Continuous Bioprocessing Market, by Application
8.1. Introduction
8.2. Commercial
8.2.1. Cell & Gene Therapy Production
8.2.2. Monoclonal Antibodies Production
8.2.3. Plasma Fractionation
8.2.4. Recombinant Protein Production
8.2.5. Vaccine Manufacturing
8.3. Research & Development
9. Americas Continuous Bioprocessing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Continuous Bioprocessing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Continuous Bioprocessing Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. 3M Company
13.2. Applikon Biotechnology B.V.
13.3. Bio-Rad Laboratories, Inc.
13.4. Bionet
13.5. Colder Products Company
13.6. Danaher Corporation
13.7. Eppendorf AG
13.8. Fujifilm Holdings Corporation
13.9. GE Healthcare
13.10. Lonza Group
13.11. Merck KGaA
13.12. Repligen Corporation
13.13. Sartorius AG
13.14. Thermo Fisher Scientific Inc.
13.15. Watson-Marlow Fluid Technology Group
13.16. WuXi Biologics
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL CONTINUOUS BIOPROCESSING MARKET: DYNAMICS
FIGURE 2. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 3. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2026
FIGURE 5. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTORS, 2018-2026 (USD MILLION)
FIGURE 6. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 7. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL CULTURE MEDIA & REAGENT, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL CULTURE MEDIA & REAGENT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 9. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CENTRIFUGES, 2018-2026 (USD MILLION)
FIGURE 10. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CENTRIFUGES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 11. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEM & CONSUMABLE, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEM & CONSUMABLE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEMS AND CONSUMABLES, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEMS AND CONSUMABLES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY INCUBATORS & SHAKERS, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY INCUBATORS & SHAKERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MIXING SYSTEMS, 2018-2026 (USD MILLION)
FIGURE 18. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MIXING SYSTEMS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 19. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
FIGURE 20. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2026
FIGURE 22. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 23. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 24. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2018-2026 (USD MILLION)
FIGURE 25. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 26. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2026 (USD MILLION)
FIGURE 27. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 28. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 29. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2026
FIGURE 31. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, 2018-2026 (USD MILLION)
FIGURE 32. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 33. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL & GENE THERAPY PRODUCTION, 2018-2026 (USD MILLION)
FIGURE 34. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL & GENE THERAPY PRODUCTION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 35. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MONOCLONAL ANTIBODIES PRODUCTION, 2018-2026 (USD MILLION)
FIGURE 36. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MONOCLONAL ANTIBODIES PRODUCTION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 37. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PLASMA FRACTIONATION, 2018-2026 (USD MILLION)
FIGURE 38. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PLASMA FRACTIONATION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 39. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEIN PRODUCTION, 2018-2026 (USD MILLION)
FIGURE 40. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEIN PRODUCTION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 41. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINE MANUFACTURING, 2018-2026 (USD MILLION)
FIGURE 42. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINE MANUFACTURING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 43. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2026 (USD MILLION)
FIGURE 44. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 45. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. GLOBAL CONTINUOUS BIOPROCESSING MARKET: FPNV POSITIONING MATRIX
FIGURE 76. GLOBAL CONTINUOUS BIOPROCESSING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 77. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CONTINUOUS BIOPROCESSING MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL CONTINUOUS BIOPROCESSING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2026 (USD MILLION)
TABLE 5. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTORS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL CULTURE MEDIA & REAGENT, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL CULTURE MEDIA & REAGENT, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL CULTURE MEDIA & REAGENT, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL CULTURE MEDIA & REAGENT, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL CULTURE MEDIA & REAGENT, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY CENTRIFUGES, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEM & CONSUMABLE, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEM & CONSUMABLE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEM & CONSUMABLE, BY STATE, 2018-2026 (USD MILLION)
TABLE 22. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEM & CONSUMABLE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CHROMATOGRAPHY SYSTEM & CONSUMABLE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 24. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEMS AND CONSUMABLES, BY REGION, 2018-2026 (USD MILLION)
TABLE 25. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEMS AND CONSUMABLES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 26. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEMS AND CONSUMABLES, BY STATE, 2018-2026 (USD MILLION)
TABLE 27. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEMS AND CONSUMABLES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY FILTRATION SYSTEMS AND CONSUMABLES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 29. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY INCUBATORS & SHAKERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 30. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY INCUBATORS & SHAKERS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 31. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY INCUBATORS & SHAKERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 32. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY INCUBATORS & SHAKERS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY INCUBATORS & SHAKERS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 34. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MIXING SYSTEMS, BY REGION, 2018-2026 (USD MILLION)
TABLE 35. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY MIXING SYSTEMS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 36. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY MIXING SYSTEMS, BY STATE, 2018-2026 (USD MILLION)
TABLE 37. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY MIXING SYSTEMS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY MIXING SYSTEMS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 39. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2026 (USD MILLION)
TABLE 40. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2026 (USD MILLION)
TABLE 41. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 42. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY STATE, 2018-2026 (USD MILLION)
TABLE 43. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 45. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2026 (USD MILLION)
TABLE 46. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 47. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY STATE, 2018-2026 (USD MILLION)
TABLE 48. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 50. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 51. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 52. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 53. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 55. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 56. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2026 (USD MILLION)
TABLE 57. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 58. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, BY STATE, 2018-2026 (USD MILLION)
TABLE 59. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 61. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL & GENE THERAPY PRODUCTION, BY REGION, 2018-2026 (USD MILLION)
TABLE 62. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL & GENE THERAPY PRODUCTION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 63. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL & GENE THERAPY PRODUCTION, BY STATE, 2018-2026 (USD MILLION)
TABLE 64. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL & GENE THERAPY PRODUCTION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL & GENE THERAPY PRODUCTION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 66. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MONOCLONAL ANTIBODIES PRODUCTION, BY REGION, 2018-2026 (USD MILLION)
TABLE 67. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY MONOCLONAL ANTIBODIES PRODUCTION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 68. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY MONOCLONAL ANTIBODIES PRODUCTION, BY STATE, 2018-2026 (USD MILLION)
TABLE 69. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY MONOCLONAL ANTIBODIES PRODUCTION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY MONOCLONAL ANTIBODIES PRODUCTION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 71. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PLASMA FRACTIONATION, BY REGION, 2018-2026 (USD MILLION)
TABLE 72. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PLASMA FRACTIONATION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 73. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PLASMA FRACTIONATION, BY STATE, 2018-2026 (USD MILLION)
TABLE 74. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY PLASMA FRACTIONATION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PLASMA FRACTIONATION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 76. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEIN PRODUCTION, BY REGION, 2018-2026 (USD MILLION)
TABLE 77. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEIN PRODUCTION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 78. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEIN PRODUCTION, BY STATE, 2018-2026 (USD MILLION)
TABLE 79. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEIN PRODUCTION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEIN PRODUCTION, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 81. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINE MANUFACTURING, BY REGION, 2018-2026 (USD MILLION)
TABLE 82. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINE MANUFACTURING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 83. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINE MANUFACTURING, BY STATE, 2018-2026 (USD MILLION)
TABLE 84. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINE MANUFACTURING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINE MANUFACTURING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 86. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2026 (USD MILLION)
TABLE 87. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 88. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY STATE, 2018-2026 (USD MILLION)
TABLE 89. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 91. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 92. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 93. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 94. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 95. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 96. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 97. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 98. AUSTRALIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 99. CHINA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 100. INDIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 101. INDONESIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 102. JAPAN CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 103. MALAYSIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 104. PHILIPPINES CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 105. SINGAPORE CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 106. SOUTH KOREA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 107. TAIWAN CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 108. THAILAND CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 110. FRANCE CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 111. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 112. ITALY CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 113. NETHERLANDS CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 114. QATAR CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 115. RUSSIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 116. SAUDI ARABIA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 117. SOUTH AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 118. SPAIN CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 119. UNITED ARAB EMIRATES CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 120. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 121. GLOBAL CONTINUOUS BIOPROCESSING MARKET: SCORES
TABLE 122. GLOBAL CONTINUOUS BIOPROCESSING MARKET: BUSINESS STRATEGY
TABLE 123. GLOBAL CONTINUOUS BIOPROCESSING MARKET: PRODUCT SATISFACTION
TABLE 124. GLOBAL CONTINUOUS BIOPROCESSING MARKET: RANKING
TABLE 125. GLOBAL CONTINUOUS BIOPROCESSING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 126. GLOBAL CONTINUOUS BIOPROCESSING MARKET: MERGER & ACQUISITION
TABLE 127. GLOBAL CONTINUOUS BIOPROCESSING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 128. GLOBAL CONTINUOUS BIOPROCESSING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 129. GLOBAL CONTINUOUS BIOPROCESSING MARKET: INVESTMENT & FUNDING
TABLE 130. GLOBAL CONTINUOUS BIOPROCESSING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 131. GLOBAL CONTINUOUS BIOPROCESSING MARKET: LICENSE & PRICING

Companies Mentioned

  • 3M Company
  • Applikon Biotechnology B.V.
  • Bio-Rad Laboratories, Inc.
  • Bionet
  • Colder Products Company
  • Danaher Corporation
  • Eppendorf AG
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Lonza Group
  • Merck KGaA
  • Repligen Corporation
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • Watson-Marlow Fluid Technology Group
  • WuXi Biologics

Methodology

Loading
LOADING...